IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.97B
1-Year Est. Return
106.57%
This Fund
S&P 500
1 Year Est. Return
+106.57%
AUM
$1.37B
AUM Growth
+$301M
(+28%)
Holding
90
Top Buys
| 1 | +$17.8M | |
| 2 | +$16.5M | |
| 3 | +$12.7M | |
| 4 |
Centene
CNC
|
+$12.1M |
| 5 |
Intuitive Surgical
ISRG
|
+$12M |
Top Sells
| 1 | +$26M | |
| 2 | +$25.9M | |
| 3 | +$17.5M | |
| 4 |
GE HealthCare
GEHC
|
+$14.8M |
| 5 |
Encompass Health
EHC
|
+$14.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$894B
| $15.3M | 1.11% |
20,000
-5,000
|
|
||
27
CVS Health
CVS
$97.1B
| $15.1M | 1.1% |
200,000
-50,000
|
|
||
28
Tarsus Pharmaceuticals
TARS
$3.11B
| $14.9M | 1.08% |
250,000
+50,000
|
|
||
29
Medtronic
MDT
$115B
| $14.3M | 1.04% |
150,000
-50,000
|
|
||
|
30
Centene
CNC
$17.9B
| $14.3M | 1.04% |
+400,000
|
|
||
31
Doximity
DOCS
$4.58B
| $13.2M | 0.96% |
+180,000
|
|
||
32
Pfizer
PFE
$154B
| $12.7M | 0.93% |
500,000
-200,000
|
|
||
33
Penumbra
PEN
$13.2B
| $12.7M | 0.92% |
50,000
+10,000
|
|
||
34
Arcellx
ACLX
$6.69B
| $12.3M | 0.9% |
+150,000
|
|
||
35
Ascendis Pharma
ASND
$14.8B
| $11.9M | 0.87% |
+60,000
|
|
||
36
Fresenius Medical Care
FMS
$12.8B
| $11.8M | 0.86% |
450,000
-300,000
|
|
||
37
McKesson
MCK
$114B
| $11.6M | 0.84% |
15,000
+5,000
|
|
||
38
Agilent Technologies
A
$32.6B
| $11.6M | 0.84% |
90,000
+40,000
|
|
||
39
Roivant Sciences
ROIV
$21.3B
| $11.3M | 0.83% |
750,000
+150,000
|
|
||
40
Envista
NVST
$4.26B
| $11.2M | 0.82% |
+550,000
|
|
||
|
41
Intuitive Surgical
ISRG
$173B
| $11.2M | 0.82% |
+25,000
|
|
||
42
iRhythm Holdings
IRTC
$3.9B
| $11.2M | 0.81% |
65,000
+25,000
|
|
||
43
Exact Sciences
EXAS
$19.7B
| $10.9M | 0.8% |
200,000
+100,000
|
|
||
|
UPB
44
Upstream Bio Inc
UPB
$439M
| $10.8M | 0.79% |
+575,000
|
|
||
45
Oric Pharmaceuticals
ORIC
$1.41B
| $10.8M | 0.79% |
900,000
-350,000
|
|
||
46
Regenxbio
RGNX
$501M
| $10.6M | 0.77% |
1,100,000
+400,000
|
|
||
47
Oscar Health
OSCR
$3.96B
| $10.4M | 0.76% |
550,000
+450,000
|
|
||
48
Dyne Therapeutics
DYN
$3.26B
| $10.1M | 0.74% |
+800,000
|
|
||
49
Biohaven
BHVN
$1.36B
| $9.76M | 0.71% |
650,000
+350,000
|
|
||
50
Beam Therapeutics
BEAM
$2.66B
| $9.71M | 0.71% |
400,000
-100,000
|
|